Navigation Links
Newly found gene variants account for kidney diseases among African-Americans
Date:9/14/2008

For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University. The findings are published online today in two papers in Nature Genetics and will be published in the October print issue.

"These two breakthrough genomic studies on kidney disease illustrate the importance of collaborations between scientists at NIH and NIH-funded investigators at Johns Hopkins," said NIH Director Elias A. Zerhouni, M.D. "This type of government-academic collaboration moves translational research forward and provides the knowledge base for developing new therapies for these chronic health disorders."

The researchers studied nondiabetic kidney diseases that can lead to chronic kidney disease and, in severe cases, to kidney failure requiring long-term dialysis or a kidney transplant. One of these diseases, focal segmental glomerulosclerosis (FSGS), is a kidney disease that leads to kidney failure in more than half of those with the disease over a period of about 10 years. Chronic kidney disease is caused by many different diseases and conditions and affects 26 million Americans. More than 106,000 individuals develop kidney failure and more than 485,000 receive dialysis or transplantation in the United States each year.

Using a type of genome association that relies on differences in the frequency of gene variants between populations, the NIH researchers identified several variations in the MYH9 gene as major contributors to excess risk of kidney disease among African-Americans. The NIH researchers shared their discovery with the Johns Hopkins scientists, who replicated the findings in participants from earlier studies of kidney disease.

Both research teams found statistically significan
'/>"/>

Contact: Arthur Stone
niddkmedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. McCulley/Cuppan Consultants Contribute Chapter to the Newly Published Book, Rhetoric of Healthcare: Essays Toward a New Disciplinary Inquiry
2. Newly-defined factors may prevent postpartum smoking relapse
3. Federal Advisory Committee Votes to Include Newly Licensed Pentacel(R) Vaccine in Vaccines for Children Program
4. Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals: Collaboration Across Industries; Alignment of Resources; Increased Awareness Among Public and Private Stakeholders Including Fede
5. Newly approved ocular safety methods reduce animal testing
6. Worlds Leading Health Experts Urge Countries to Use Newly Released Data to Prevent the Death of Millions of Children Due to Rotavirus
7. IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE)
8. Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohns Patients
9. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
10. Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate
11. Newly diagnosed breast cancer patients benefit from use of USFNA of lymph nodes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Churchill C...Award For Leadership to J.W. "Bill" Marriott for h...ugh progressive free market practices and fosterin... Mr. Marriott will receive his award at a ceremony...ton D.C. Four Seasons Hotel. ,, "This is a tes...
(Date:11/9/2009)...elped men and women almost equally, study finds, ...he widely used clot-dissolving drug Plavix (clopid... analysis of major clinical trials has found. ,...in treating both men and women with this very impo...of cardiovascular thrombosis at New York Universit...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it...tion, according to TOPS Club, Inc. (Take Off Pound...anization. , (Vocus) Nove...omes to preventing or improving a diabetes conditi...Sensibly), the nonprofit weight-loss support organ...
(Date:11/9/2009)...BANON, Tenn., Nov. 9 Health Connec...nced it will host their inaugural Hospital O.R. an... at the Marriott Renaissance Hotel in Nashville, T...re than 100 hospital operating room directors and ...alth systems in the country. Some of the confirmed...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...al shows novel compound blocks enzyme triggering c...4 (HealthDay News) -- A drug designed to lessen mu... safety tests in humans. , The drug, known as KAI-...ervention (PCI). PCI is a set of procedures includ...
...reading of screening mammograms with computer-aide...ading and yields a higher sensitivity than the fir...o a study conducted by researchers at Charlotte Ra...onsisted of the mammogram being first read by sub-...
...echnique that combines bone marrow removal and inj...of new bone at targeted locations in the body, it ... in Tissue Engineering. , "This could radically c...gns Vignery , associate professor of orthopedics ...
...O(TM) Beverage Provides Refreshing Taste with Bene... International today,launches HIRO(TM) Super Fruit...its popular HIRO(TM) ready-to-drink noni-based bev...pe., HIRO Super Fruits Sparkling Black Currant is...
..., Feb. 14 Today, the Centers for,Disease Control ...sting,performed on occupied FEMA travel trailers. ... testified before the Committee on Homeland,Securi...associated with prolonged formaldehyde exposure ca...
...aeli scientist, Dr. Siegal Sadetzki, has found a l...f tumors. , Dr. Sadetzki, a physician, epidemiol...ed the results of a study recently in the American...rs of the salivary gland. , Those who used a cel...
Other Medicine News:Health News:Drug Cuts Muscle Damage After Heart Attack 2Health News:Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive 2Health News:Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant 2Health News:Thompson Demands Solution to Formaldehyde Trailer Crisis 2Health News:Cell phone-cancer link found by Tel Aviv University scientist 2
(Date:11/9/2009)...ION, N.J., Nov. 9 Unwavering from ...s, but recognizing today,s economic climate, Lutro...thetic laser systems, introduces the MOSAIC CO2, a...er $50,000. ,, The MOSAIC CO2 offers many of t...logy including scanning and stamping operation mod...
(Date:11/9/2009)... Nov. 9 Decision Resources, one of...or pharmaceutical and healthcare issues, finds tha... 2 (HER2) targeting therapies -- which include Roc...ayaku,s Tykerb/Tyverb -- were the highest-selling ...ptake of Herceptin and Tykerb/Tyverb and the expec...
(Date:11/9/2009)... Nov. 9 ARmark Authentication Tech...an alliance in the development and introduction of...ion technology that incorporates microscopic cover...ngs of solid oral dosage forms (SODFs) to prevent ...lusive rights to market ARmark,s micro-tags for ta...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 1The Sloane Clinic pioneers Ultherapy in Singapore 54003 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 3
...ntinues to anticipate CHMP opinion in the third qu...mission decision in the fourth ...Pharma, Inc.,(Nasdaq: IDMI ) today announced that...requested additional data analyses from the Phase ...o complete the additional data,analyses, respond t...
...ss., July 1 Echo Therapeutics,Inc. (OTC Bulletin ... a,clinical study of its Symphony(TM) Transdermal ... in patients with Type 1 and Type 2,diabetes. The ...ts of the,study in the third quarter of 2008. Echo...ts Prelude(TM) SkinPrep System, which incorporates...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 2Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 3
Shandon Slide Drying Hotplate
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer)
Liquichek Blood Gas Plus CO-Oximeter Control (IL)
Liquichek Cardiac Markers Control
Medicine Products: